EIM
NMTC icon

Essex Investment Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Essex Investment Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$132K Sell
43,578
-81
-0.2% -$331 0.02% 232
2026
Q1 		$203K Buy
43,659
+12,254
+39% +$58.9K 0.03% 200
2025
Q4 		$143K Buy
+31,405
New +$143K 0.02% 221

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Essex Investment Management's NMTC Position: Q2 2026 in Review

Essex Investment Management reduced its NeuroOne Medical Technologies (NMTC) stake by 0.19% in Q2 2026, selling an estimated $331 and leaving 43,578 shares worth $132K. The position accounts for 0.02% of the portfolio, ranked #232.

Essex Investment Management first reported a position in NMTC in Q4 2025 and has held it in 3 quarters since. The position peaked at $203K in Q1 2026. 26 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Essex Investment Management held 43,578 shares of NeuroOne Medical Technologies worth $132K as of Q2 2026.
  • Essex Investment Management sold 81 NeuroOne Medical Technologies shares in Q2 2026, an estimated $331.
  • NeuroOne Medical Technologies made up 0.02% of Essex Investment Management's portfolio in Q2 2026, its #232 holding.
  • Essex Investment Management first reported a position in NeuroOne Medical Technologies in Q4 2025 and has held it in 3 quarters since.
  • Essex Investment Management's NeuroOne Medical Technologies position peaked at $203K in Q1 2026.
  • 26 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Essex Investment Management's 13F filing for Q2 2026, filed 6 Aug 2026.